Product Images Abiraterone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Abiraterone NDC 82249-010 by Civicascript, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

abiraterone-chem-structure - abiraterone tablets civicascript llc 1

abiraterone-chem-structure - abiraterone tablets   civicascript llc 1

bl-250mg-120s - abiraterone tablets civicascript llc 7

bl-250mg-120s - abiraterone tablets   civicascript llc 7

This is a description of a medication called Abiraterone Acetate. It comes in a tablet form containing 250mg of the medicine that should be swallowed whole and not chewed or crushed. There are 120 tablets in the container. The tablets are only for use by men and need to be kept out of the reach of children. There is a warning, forbidding women who are pregnant or may become so, to avoid handling the tablets without gloves, as indicated in its package insert. It is recommended to store the medicine at controlled room temperatures, between 15 °C to 30 °C. For complete information on the dosage, consult the accompanying product literature. The manufacturing company is located in Utah.*

figure-1 - image 01

figure-1 - image 01

This appears to be a graph showing the "Time to death" in months for two groups: one that was given Abiraterone Acetate and another that was given a placebo. The % Survival is not available as it seems to be cut off.*

figure-2 - image 02

figure-2 - image 02

This seems to be a table displaying information about "Subjects without Death" over a period of months from randomization, for two groups - "Abiraterone Acetate" and "Placebo". There are two columns for each month - one for each group, and the corresponding value represents the number of subjects without death. The data seems to be obtained through a clinical study, probably related to some treatment.*

figure-3 - image 03

figure-3 - image 03

figure-4 - image 04

figure-4 - image 04

This appears to be a chart or graph that shows data related to a study involving a treatment called Abiraterone acetate and a placebo. The X-axis is labeled in months from randomization and the Y-axis appears to show subjects at risk. The chart includes data for both treatments and shows the number of subjects at risk over the course of the study.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.